Mediwound Ltd. balance sheet MDWD

Annual Quarterly

As of Dec 31, 2025, Mediwound Ltd. had total assets of $86.3 million and total liabilities of $42.6 million. Total assets were up 17.4% from a year earlier. Stockholders' equity was $43.6 million. It held $4.8 million in cash and investments against $8.2 million of total debt, net debt of $3.4 million. The current ratio, current assets divided by current liabilities, was 2.33.

USD in millions, except ratios and per-share amounts. The percent under a figure is the change from the year before.

FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
FY 2019
Dec 31, 2019
FY 2018
Dec 31, 2018
FY 2017
Dec 31, 2017
Assets
Cash
5
-47.6%
9
-22.8%
12
-65.0%
34
+206.9%
11
-36.4%
17
+139.9%
7
+7.8%
7
-81.4%
36
Cash and investments
5
-47.6%
9
-22.8%
12
-65.0%
34
+206.9%
11
-36.4%
17
+139.9%
7
+7.8%
7
-81.4%
36
Inventory
4
+52.0%
3
-5.4%
3
+45.0%
2
+63.6%
1
-13.0%
1
-14.4%
2
-4.0%
2
-10.9%
2
Total current assets
60
+15.0%
52
+5.0%
50
+8.4%
46
+206.6%
15
-42.9%
26
-26.5%
36
+8.9%
33
-21.2%
42
Property and equipment, net
19
+31.9%
14
+53.1%
9
+290.0%
2
-4.5%
2
-5.8%
3
+14.1%
2
+14.1%
2
+5.0%
2
Total assets
86
+17.4%
73
+10.6%
66
+32.9%
50
+153.3%
20
-36.5%
31
-23.5%
41
+15.1%
35
-20.1%
44
Liabilities and equity
Accounts payable
8
+44.8%
5
—
—
—
—
—
—
—
Total current liabilities
26
-3.1%
27
+46.4%
18
+50.3%
12
+12.5%
11
+29.7%
8
-20.3%
10
+111.8%
5
-9.9%
5
Total liabilities
43
+0.7%
42
+21.5%
35
-10.8%
39
+60.7%
24
—
—
—
—
Stockholders' equity
44
+40.1%
31
-1.4%
32
+189.5%
11
+338.2%
-5
-163.0%
7
-52.1%
15
+69.1%
9
-4.3%
9
Debt
Lease liabilities
8
+25.2%
7
+2.6%
6
+650.6%
1
-39.2%
1
-20.1%
2
-32.4%
3
—
—
Total debt
8
+25.2%
7
+2.6%
6
+650.6%
1
-39.2%
1
-20.1%
2
-32.4%
3
—
—
Net cash
-3
-226.9%
3
-52.1%
6
-83.3%
33
+242.3%
10
-38.2%
16
+235.0%
5
—
—
Ratios
Current ratio
2.33x
1.97x
2.74x
3.80x
1.39x
3.17x
3.43x
6.68x
7.64x
Debt to equity
0.19x
0.21x
0.20x
0.08x
—
0.24x
0.17x
—
—
Debt to EBITDA
—
—
—
—
—
—
0.51x
—
—
Return on equity
-54.73%
-97.02%
-21.26%
-179.58%
—
-126.46%
32.67%
-11.78%
-236.36%
Return on assets
-27.68%
-41.12%
-10.11%
-39.19%
-68.63%
-29.60%
12.21%
-3.00%
-50.18%
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except ratios and per-share amounts. Cash and investments adds short-term and long-term marketable securities to cash. Debt due within a year is the borrowings that are not already in long-term debt. Total debt is those borrowings plus lease liabilities. Net cash is cash and investments minus total debt. Return on equity and return on assets divide the trailing twelve months of net income by the balance on that date. Debt to EBITDA uses the trailing twelve months of EBITDA. More on our methodology.

Company profile

Industry
Medicinal Chemicals & Botanical Products (SIC 2833)
Listed as
MDWD (Nasdaq)
Fiscal year ends
December 31
Incorporated in
Israel
Headquarters
Yavne, Israel
SEC filer status
Accelerated filer
SEC CIK
1593984

Other Medicinal Chemicals & Botanical Products companies

All 43 Medicinal Chemicals & Botanical Products companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.